Report post

Why did biovie Inc (BIVI) stock plunge 61%?

BioVie (BIVI) stock plunges 61% in spite of positive phase III Alzheimer's Disease study results due to significant study conduct violations and protocol deviations reported by the company. Get the latest BioVie Inc. (BIVI) stock news and headlines to help you in your trading and investing decisions.

How has Bivi stock performed over the past month?

Actively observing the price movement in the last trading, the stock closed the session at $5.89, falling within a range of $5.90 and $9.68. The value of beta (5-year monthly) was 2.48. Referring to stock’s 52-week performance, its high was $8.26, and the low was $1.33. On the whole, BIVI has fluctuated by 101.77% over the past month.

Is biovie Inc (BIVI) a good stock to buy?

BioVie Inc. (BIVI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

The World's Leading Crypto Trading Platform

Get my welcome gifts